Form D · Biotechnology

Chimeron Bio Corp

Philadelphia, PA · CIK 0001837360

Offering snapshot reported Mar 14, 2025 · SEC filing

Reported sold: $12.8M
Investors reported: 9
Minimum accepted: $0
First sale: Mar 25, 2024

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$13,736,689 → $12,811,690

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 14, 2025	Amendment	$12,811,690	-$924,999vs Mar 3, 2025	9	SEC filing
Mar 3, 2025	Initial	$13,736,689	No comparison	9	SEC filing
Nov 30, 2022	Initial	$1,200,000	No comparison	3	SEC filing
Mar 10, 2022	Initial	$782,000	No comparison	1	SEC filing
Dec 28, 2020	Initial	$300,000	No comparison	2	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-539637

Source: Form D, filed Mar 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Thimmaiah Chendrimada	Executive
Monica Coleman	Executive
Antonin De Fougerolles	Director
Gorka Fius	Director
Kevin Heyeck	Director, Executive
Jolly Mazmudar	Director, Executive
Hemanshu Pandya	Director
Chiraag Patel	Director
Afshin Safavi	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

601 Walnut Street, Suite 715
Philadelphia, PA, 19106